Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Share-based Compensation (2016 - 2024)

Sunshine Biopharma (SBFM) has disclosed Share-based Compensation for 9 consecutive years, with $12000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Share-based Compensation changed N/A year-over-year to $12000.0, compared with a TTM value of $12000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $12000.0, changed N/A over the prior year.
  • Share-based Compensation was $12000.0 for Q1 2024 at Sunshine Biopharma, down from $918000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $918000.0 in Q1 2021 and bottomed at $12000.0 in Q1 2024.
  • Average Share-based Compensation over 3 years is $326666.7, with a median of $50000.0 recorded in 2020.